Determining the phagocytic activity of clinical antibody samples

Journal of Visualized Experiments

Volumn , Issue 57, 2011, Pages

  Mcandrew, Elizabeth G ^a   Dugast, Anne Sophie ^a   Licht, Anna F ^a   Eusebio, Justin R ^a   Alter, Galit ^a   Ackerman, Margaret E ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b DARTMOUTH COLLEGE   (United States)

Author keywords

Adcc; Antibody; Antibody dependent phagocytosis; Effector function; Fc receptor; Immunology; Issue 57; Monocytes; Phagocytosis

Indexed keywords

EID: 83455225449     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3588     Document Type: Article

References (18)

1. Cartron, G., et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood. 99, 754-758 (2002).
2. Ahmad, R., et al. Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection. J. Clin. Immunol. 21, 227-233 (2001).
3. Hashimoto, G., Wright, P.F., & Karzon, D.T. Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J. Infect Dis. 148, 785-794 (1983).
4. Anthony, R.M., & Nimmerjahn, F. The role of differential IgG glycosylation in the interaction of antibodies with FcgammaRs in vivo. Curr. Opin. Organ Transplant, doi:10.1097/MOT.0b013e328342538f (2010).
5. Takai, T. Fc receptors and their role in immune regulation and autoimmunity. J. Clin. Immunol. 25, 1-18, doi:10.1007/s10875-005-0353-8 (2005).
6. Jefferis, R. Antibody therapeutics: isotype and glycoform selection. Expert. Opin. Biol. Ther. 7, 1401-1413, doi:10.1517/14712598.7.9.1401 (2007).
7. Halstead, S.B. & O'Rourke, E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146, 201-217 (1977).
8. Subramaniam, K.S., et al. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J. Immunol. 184, 5755-5767, doi:jimmunol.0901638 [pii] 10.4049/jimmunol.0901638 (2010).
9. Ackerman, M.E., et al. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. J. Immunol. Methods. 366, 8-19, doi:S0022-1759(10)00393-5 [pii] 10.1016/j.jim.2010.12.016 (2011).
10. Tsuchiya, S., et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer. 26, 171-176 (1980).
11. Ward, E.S., & Ghetie, V. The effector functions of immunoglobulins: implications for therapy. Ther. Immunol. 2, 77-94 (1995).
12. Winiarska, M., Glodkowska-Mrowka, E., Bil, J., & Golab, J. Molecular mechanisms of the antitumor effects of anti-CD20 antibodies. Front. Biosci. 16, 277-306, doi:3688 [pii] (2011).
13. Takai, T. Fc receptors: their diverse functions in immunity and immune disorders. Springer Semin. Immunopathol. 28, 303-304, doi:10.1007/s00281-006-0055-y (2006).
14. Yamaguchi, Y., et al. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim. Biophys. Acta. 1760, 693-700, doi:S0304-4165(05)00319-3 [pii] 10.1016/j.bbagen.2005.10.002 (2006).
15. Anthony, R.M. & Ravetch, J.V. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J. Clin. Immunol. 30 Suppl 1, S9-S14, doi:10.1007/s10875-010-9405-6 (2010).
16. Nimmerjahn, F., Anthony, R.M., & Ravetch, J.V. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc. Natl. Acad. Sci. U. S. A. 104, 8433-8437, doi:0702936104 [pii] 10.1073/pnas.0702936104 (2007).
17. Marchette, N.J., et al. Effect of immune status on dengue 2 virus replication in cultured leukocytes from infants and children. Infect. Immun. 24, 47-50 (1979).
18. Fust, G., et al. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease. AIDS. 8, 603-609 (1994).